180 related articles for article (PubMed ID: 31471715)
1. Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
Jang H; Kim HJ; Park S; Park YH; Choe Y; Cho H; Lyoo CH; Yoon U; Lee JS; Kim Y; Kim SJ; Kim JP; Jung YH; Ryu YH; Choi JY; Moon SH; Seong JK; DeCarli C; Weiner MW; Lockhart SN; Cho SH; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):292-303. PubMed ID: 31471715
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.
Kim HJ; Park S; Cho H; Jang YK; San Lee J; Jang H; Kim Y; Kim KW; Ryu YH; Choi JY; Moon SH; Weiner MW; Jagust WJ; Rabinovici GD; DeCarli C; Lyoo CH; Na DL; Seo SW
JAMA Neurol; 2018 Aug; 75(8):999-1007. PubMed ID: 29799981
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.
Jang H; Kim HJ; Choe YS; Kim SJ; Park S; Kim Y; Kim KW; Lyoo CH; Cho H; Ryu YH; Choi JY; DeCarli C; Na DL; Seo SW;
J Alzheimers Dis; 2020; 78(2):573-585. PubMed ID: 33016911
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cerebrovascular Disease in Amyloid Deposition.
Noh Y; Seo SW; Jeon S; Lee JM; Kim JS; Lee JH; Kim JH; Kim GH; Ye BS; Cho H; Kim HJ; Yoon CW; Choe YS; Lee KH; Weiner MW; Na DL
J Alzheimers Dis; 2016 Oct; 54(3):1015-1026. PubMed ID: 27567803
[TBL] [Abstract][Full Text] [Related]
5. Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
Jung NY; Han JC; Ong YT; Cheung CY; Chen CP; Wong TY; Kim HJ; Kim YJ; Lee J; Lee JS; Jang YK; Kee C; Lee KH; Kim EJ; Seo SW; Na DL
J Neurol Sci; 2019 Jan; 396():94-101. PubMed ID: 30447606
[TBL] [Abstract][Full Text] [Related]
6. Association between
Lee JS; Lee H; Park S; Choe Y; Park YH; Cheon BK; Hahn A; Ossenkoppele R; Kim HJ; Kim S; Yoo H; Jang H; Cho SH; Kim SJ; Kim JP; Jung YH; Park KC; DeCarli C; Weiner MW; Na DL; Seo SW
Neurology; 2020 Oct; 95(17):e2354-e2365. PubMed ID: 32928967
[TBL] [Abstract][Full Text] [Related]
7. Distinct spatiotemporal patterns of cortical thinning in Alzheimer's disease-type cognitive impairment and subcortical vascular cognitive impairment.
Kim J; Kim J; Park YH; Yoo H; Kim JP; Jang H; Park H; Seo SW
Commun Biol; 2024 Feb; 7(1):198. PubMed ID: 38368479
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers.
Kim SE; Kim HJ; Jang H; Weiner MW; DeCarli C; Na DL; Seo SW
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142419
[TBL] [Abstract][Full Text] [Related]
9. Cortical neuroanatomical changes related to specific neuropsychological deficits in subcortical vascular cognitive impairment.
Kang SH; Park YH; Kim JP; Kim JS; Kim CH; Jang H; Kim HJ; Koh SB; Na DL; Chin J; Seo SW
Neuroimage Clin; 2021; 30():102685. PubMed ID: 34215155
[TBL] [Abstract][Full Text] [Related]
10. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
11. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
12. Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers.
Jang H; Park J; Woo S; Kim S; Kim HJ; Na DL; Lockhart SN; Kim Y; Kim KW; Cho SH; Kim SJ; Seong JK; Seo SW;
Neuroimage Clin; 2019; 24():101941. PubMed ID: 31376643
[TBL] [Abstract][Full Text] [Related]
13. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
[TBL] [Abstract][Full Text] [Related]
14. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
15. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Amyloid Positivity in Patients with Subcortical Vascular Cognitive Impairment.
Moon H; Ham H; Yun J; Shin D; Lee EH; Kim HJ; Seo SW; Na DL; Jang H
J Alzheimers Dis; 2024; 99(3):1117-1127. PubMed ID: 38788077
[TBL] [Abstract][Full Text] [Related]
17. Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type.
Lagarde J; Olivieri P; Tonietto M; Gervais P; Comtat C; Caillé F; Bottlaender M; Sarazin M
Transl Psychiatry; 2021 Sep; 11(1):498. PubMed ID: 34588422
[TBL] [Abstract][Full Text] [Related]
18. Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment.
Kim HR; Jung SH; Kim B; Kim J; Jang H; Kim JP; Kim SY; Na DL; Kim HJ; Nho K; Won HH; Seo SW
Front Aging Neurosci; 2023; 15():1160536. PubMed ID: 37143691
[TBL] [Abstract][Full Text] [Related]
19. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P
Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623
[TBL] [Abstract][Full Text] [Related]
20. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
